HOME >> BIOLOGY >> NEWS
Salk polio vaccine celebrates 50th anniversary

WHITE PLAINS, MARCH 28, 2005 -- Polio, one of the most dreaded epidemic diseases in history, went on its way to defeat 50 years ago with the announcement of the first safe and effective polio vaccine, developed by Dr. Jonas Salk and supported by the March of Dimes.

The menace of death or paralysis from polio, a viral infection that affected mostly children, caused widespread fear and panic in the United States for decades. Sporadic and unpredictable outbreaks of the disease marked the lives of Americans during the first half of the 20th century. In 1952, the most severe polio epidemic year on record, more than 57,800 people were stricken with the disease. The images of youngsters in wheelchairs, on crutches, or in unwieldy "iron lungs" responsible for their every breath, haunted parents.

In the spring of 1954, the March of Dimes (then known formally as the National Foundation for Infantile Paralysis) conducted the largest clinical trial in U.S. history, testing the vaccine developed by Jonas Salk, M.D, on more than 1.8 million schoolchildren. Thousands of health care workers and other volunteers across the country participated to make it possible.

No wonder, then, that millions of anxious Americans held their breath with anticipation when the results of the field trials were announced on April 12, 1955. Under the penetrating gaze of hundreds of journalists and the glare of camera lights at the University of Michigan, it was announced that the vaccine worked -- polio now could be prevented. A huge outpouring of relief and joy greeted the news, and Dr. Salk became a national hero overnight.

Significance of the Anniversary

Many other medical advances were made possible by the wide net that was cast in funding the quest for a polio vaccine. "Most of the beginnings of molecular biology were financed by the March of Dimes as part of its study of viruses in search of a vaccine," said Victor A. McKusick, M.D., the noted
'"/>

Contact: Michele Kling
mkling@marchofdimes.com
914-997-4613
March of Dimes Birth Defects Foundation
24-Mar-2005


Page: 1 2 3

Related biology news :

1. What led to the Nigerian boycott of the polio vaccination campaign?
2. Researchers use poliovirus to destroy neuroblastoma tumors in mice
3. Science study explains polios tenacious grip in India
4. Scientific institute founded by Jonas Salk to host meeting for polio survivors on Oct. 27
5. Leslie Roberts, Science Deputy News Editor, wins prize for first-rate polio story
6. Survivors to revisit the polio scare
7. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer
8. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
9. Handicapping tuberculosis may be the way to a better vaccine
10. Developing a more effective vaccine for tuberculosis
11. New target for HIV/AIDS drugs and vaccine discovered

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Salk polio vaccine celebrates anniversary

(Date:5/23/2013)... history museums of the world are billions of animal ... flowers, mushrooms and grasses, all stacked, stored and preserved ... diverse collections could be critical to understanding how the ... growing human footprint if only the information were ... life with the help of a team from the ...
(Date:5/23/2013)... when microbial pathogens are growing increasingly resistant to the ... of Wisconsin scientists has synthesized a potent new class ... staph infections. , Writing online in the Journal ... by University of Wisconsin-Madison chemistry Professor Helen Blackwell describes ... of Staphylococcus aureus , a bacterium at the ...
(Date:5/22/2013)... cell powered buses, including a team from Simon ... processes and bus membrane durability. , The team ... in the operating cycle of the bus on ... study, led by SFU graduate student Natalia MaCauley, ... Burnaby-based Ballard Power Systems and funded by Automotive ...
Breaking Biology News(10 mins):CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4University of Wisconsin chemists find new compounds to curb staph infection 2Tests lead to doubling of fuel cell life 2
(Date:5/23/2013)... -- Rahal Letterman Lanigan Racing (RLL) and StemCyte, Inc., a ... and therapeutics, announced today that StemCyte has become an ... car driven by James Jakes . ... 2013 season.   StemCyte, Inc. and Rahal Letterman ... umbilical cord blood banking and its educational initiative ,Stars ...
(Date:5/23/2013)... , May 23, 2013 Virobay, Inc. today ... pain has reached an important milestone, as Virobay has ... - a selective cathepsin S inhibitor.   ... double-blind, randomized, placebo-controlled study designed to evaluate the safety, ... in healthy adults. "The initiation of this ...
(Date:5/23/2013)... The New Jersey chapter of the largest ... Associates (BDPA), is hosting its 10th annual Families in ... event will encourage students and their parents to explore ... from many of the industries’ finest teachers. Held from ... Institute of Technology, the event will include workshops, instruction ...
(Date:5/23/2013)... Ariz. (PRWEB) May 23, 2013 SynCardia ... first and only FDA, Health Canada and CE (Europe) ... Science Centre in Scotland, which boasts more than 380,000 ... Artificial Heart powered by the Freedom® portable driver ... of the most advanced exhibitions of its kind. ...
Breaking Biology Technology:StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
Cached News: